title: Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
authors.affiliation: Department of Surgery, University of Chicago, Illinois 60637, USA.
authors.forename: D S
authors.initials: DS
authors.lastname: Bruce
authors.forename: E S
authors.initials: ES
authors.lastname: Woodle
authors.forename: K A
authors.initials: KA
authors.lastname: Newell
authors.forename: J M
authors.initials: JM
authors.lastname: Millis
authors.forename: D C
authors.initials: DC
authors.lastname: Cronin
authors.forename: G E
authors.initials: GE
authors.lastname: Loss
authors.forename: H P
authors.initials: HP
authors.lastname: Grewal
authors.forename: C T
authors.initials: CT
authors.lastname: Siegel
authors.forename: S
authors.initials: S
authors.lastname: Pellar
authors.forename: M A
authors.initials: MA
authors.lastname: Josephson
authors.forename: J R
authors.initials: JR
authors.lastname: Thistlethwaite
mesh_terms: D001682:Biological Availability; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D016035:Pancreas Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D012008:Recurrence; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D016559:Tacrolimus